Besides, Kla incorporates target therapy resistance.233,234 Scientists demonstrated downregulation of histone Kla enhanced the sensitivity of CRC cells to bevacizumab treatment in cell-based xenografts, patient-derived xenografts and patient-derived organoids models, which further broadens the role of Kla in antiangiogenic therapy.230. The gene discussed is KL; the disease is colorectal carcinoma.